{"id":666,"date":"2023-01-05T10:24:06","date_gmt":"2023-01-05T01:24:06","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=666"},"modified":"2023-01-05T12:03:17","modified_gmt":"2023-01-05T03:03:17","slug":"2022-2","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/works\/2022-2\/","title":{"rendered":"2022"},"content":{"rendered":"\n

\u539f\u8457\u8ad6\u6587<\/strong><\/span><\/p>\n

    \n
  1. Sasaki S, Nishihira K, Yamashita A, Fujii T, Onoue K, Saito Y, Hatakeyama K, Shibata Y, Asada Y, Ohbayashi C. Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome. PLoS One. 2022; 17: e0262413.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/li>\n
  2. Goto T, Sato Y, Kodama Y, Tomimori K, Sameshima H, Aman M, Maekawa K,\u00a0Yamashita A, Asada Y. Association between fetal vascular malperfusion and gestational diabetes. J Obstet Gynaecol Res. 2022; 48: 80-86. \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/span><\/li>\n
  3. Tomimori K, Kodama Y, Tanaka H,\u00a0Yamashita A, Gi T, Asada Y, Doi K, Katsuragi S, Sato Y. Myeloid cell thrombus and fetal vascular malperfusion in placentas with transient abnormal myelopoiesis. Virchows Arch. 2022; 480: 1181-1187. \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/span><\/li>\n
  4. Tsuruda T,\u00a0Yamashita A, Otsu M, Koide M, Nakamichi Y, Sekita-Hatakeyama Y, Hatakeyama K, Funamoto T, Chosa E, Asada Y, Udagawa N, Kato J, Kitamura K. Angiotensin II induces aortic rupture and dissection in osteoprotegerin-deficient mice. J Am Heart Assoc. 2022; 11: e025336.<\/span><\/li>\n
  5. Tomimori-Gi K, Katsuragi S, Kodama Y, Yamada N, Sameshima H, Maekawa K,\u00a0Yamashita A, Gi T, Sato Y. Low-dose aspirin therapy improves decidual arteriopathy in pregnant women with a history of preeclampsia. Virchows Arch. 2022; 481: 713-720. \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/li>\n
  6. Otani T, Nishihira K, Azuma Y,\u00a0Yamashita A, Shibata Y, Asada Y, Hatakeyama K. Chlamydia pneumoniae<\/em>\u00a0is prevalent in symptomatic coronary atherosclerotic plaque samples obtained from directional coronary atherectomy, but its quantity is not associated with plaque instability: An immunohistochemical and molecular study. Clin Pathol. 2022; 15: 2632010X221125179. \u00a0 \u00a0 \u00a0\u00a0<\/span><\/li>\n
  7. Shimizu H, Hatakeyama K, Saito K, Shobatake R, Takahashi N, Deguchi J, Tokunaga H, Shimada K, Nakagawa I, Myochin K, Sakai K, Kubo M,\u00a0Yamashita A, Obayashi C, Sugie K, Matsumoto M. Age and composition of the thrombus retrieved by mechanical thrombectomy from patients with acute ischemic stroke are associated with revascularization and clinical outcomes. Thromb Res. 2022; 219: 60-69. \u00a0\u00a0<\/span><\/li>\n
  8. Murakami M, Murakami AM, Nemoto T, Ohba T, Yonekura M, Toyama Y, Tomita H, Matsuzaki Y, Sawamura D, Hirota K, Itagaki S,\u00a0Asada Y, Miyoshi I. Enhanced \u03b2-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel. PLoS One. 2022; 17: e0261668.<\/span><\/li>\n
  9. Okabe H, Kato H, Yoshida M, Kotake, M, Tanabe R, Matano Y, Yoshida M, Nomura S, Yamashita A, Nagai N. Inflammatory response induced in pulmonary embolic lung: evaluation using a reproducible murine pulmonary embolism model. Glob J Agric Health Sci. 2022; 11. DOI: 10.35248\/2319-5584.22.11.141\u00a0<\/span><\/li>\n<\/ol>\n

    \u75c7\u4f8b\u5831\u544a<\/strong><\/span><\/p>\n

      \n
    1. Gi T, Nishino S,\u00a0Yamashita A, Watanabe N, Shibata Y, Asada Y. Multiple asymptomatic coronary plaque ruptures and fissures in acute myocardial infarction. Pathol Int. 2022; 72: 355-357.\u00a0<\/span><\/li>\n
    2. Kuroki S, Ayabe T, Gi T, Sato Y, Nakada H, Maeda R. Intrapulmonary solitary fibrous tumor coexisting with lung adenocarcinomas. Surg Case Rep. 2022; 8:150.<\/span><\/li>\n
    3. \u9ed2\u6728\u76f4\u7f8e\u3001\u5ddd\u53e3\u3000\u99ff\u3001\u9577\u4e45\u4fdd\u6e90\u592a\u3001\u5c71\u672c\u68ee\u592a\u90ce\u3001\u7530\u4e2d\u667a\u7ae0\u3001\u83c5\u702c\u9686\u4fe1\u3001\u7a32\u7559\u76f4\u6a39\u3001\u5317\u689d\u3000\u6d69\u3001\u8c37\u53e3\u6b63\u6b21\u3001\u6307\u5bbf\u4e00\u5f66\u3001\u5f8c\u85e4\u3000\u5d07\u3001\u53e4\u8cc0\u502b\u592a\u90ce\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5c0f\u677f\u88d5\u4e4b\u3001\u81fc\u9593\u5eb7\u535a\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u5225\u5e9c\u6a39\u4e00\u90ce\u3001\u4e38\u585a\u6d69\u52a9.\u3000\u81b5\u764c\u8853\u5f8c\u306e\u80ba\u8ee2\u79fb\u5207\u9664\u3067\u9577\u671f\u751f\u5b58\u3092\u5f97\u3066\u3044\u308b2\u4f8b. \u5bae\u5d0e\u533b\u4f1a\u8a8c 2022; 46: 180-188.<\/span><\/li>\n
    4. \u9ed2\u6728\u76f4\u7f8e\u3001\u8c37\u53e3\u6b63\u6b21\u3001\u5f8c\u85e4\u3000\u5d07\u3001\u5185\u5c71\u5c1a\u7f8e\u3001\u9ed2\u6728\u66a2\u4e00\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5c0f\u677f\u88d5\u4e4b\u3001\u81fc\u9593\u5eb7\u535a.\u3000Conversion surgery\u5f8c\u80ba\u8ee2\u79fb\u306b\u5bfe\u30572\u5ea6\u306e\u80ba\u5207\u9664\u3092\u884c\u3044\u3001\u9577\u671f\u751f\u5b58\u3057\u3066\u3044\u308b\u5c40\u6240\u9032\u884c\u5207\u9664\u4e0d\u80fd\u80c6\u56a2\u764c\u306e1\u4f8b.\u3000\u80c6\u90532022; 36: 544-552<\/span><\/li>\n
    5. \u690d\u7530\u96c4\u4e00\u3001\u7267\u91ce\u88d5\u5b50\u3001\u897f\u7530\u5353\u5f18\u3001\u843d\u5408\u6634\u4e00\u90ce\u3001\u4e38\u585a\u6d69\u52a9\u3001\u76db\u53e3\u6e05\u9999\u3001\u5927\u53cb\u76f4\u6a39\uff0e\u6a19\u6e96\u6cbb\u7642\u7d42\u4e86\u5f8c\u306b\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fbFoundationOneR<\/sup>CDx\u3067ERBB2\u907a\u4f1d\u5b50\u306e\u5897\u5e45\u3092\u8a8d\u3081\u6297HER2\u7642\u6cd5\u304c\u594f\u529f\u3057\u305f\u8ee2\u79fb\u6027\u4e73\u764c\u306e\u4e00\u4f8b\uff0e\u65e5\u5927\u533b\u5b66\u96d1\u8a8c 2022; 81: 155-159<\/span><\/li>\n
    6. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u524d\u5ddd\u4e00\u4e5f\u3001\u76db\u53e3\u6e05\u9999\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u6d45\u7530\u88d5\u58eb\u90ce\u3001\u5927\u6fa4\u7dbe\u5b50\u3001\u85e4\u5d0e\u78a7\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u5927\u897f\u6df3\u4ec1\u3001\u6842\u6728\u771f\u53f8\uff0e\u795e\u7d4c\u5185\u5206\u6ccc\u5206\u5316\u6210\u5206\u3092\u4f34\u3063\u305f\u5375\u5de3\u985e\u5185\u819c\u764c\u306e\uff11\u4f8b\uff0e\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c 2022; 13: 29-32<\/span><\/li>\n
    7. \u7576\u702c\u3061\u3072\u308d\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u4f50\u85e4\u8b19\u6210\u3001\u5927\u6fa4\u7dbe\u5b50\u3001\u5713\u5d0e\u590f\u7f8e\u3001\u690d\u91ce\u5178\u5b50\u3001\u85e4\u5d0e \u78a7, \u5927\u6817\u4f38\u884c\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5927\u897f\u6df3\u4ec1\u3001\u6842\u6728\u771f\u53f8\uff0e\u6025\u901f\u306b\u81e8\u5e8a\u6240\u898b\u304c\u9032\u884c\u3057\u4e88\u5f8c\u4e0d\u826f\u3067\u3042\u3063\u305fp53\u967d\u6027\u5b50\u5bae\u4f53\u90e8\u985e\u5185\u819c\u764c\u306e1\u4f8b\uff0e\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c2022; 46: 32-37<\/span><\/li>\n
    8. \u4eca\u91cc\u7f8e\u5e78\u3001\u68b6\u539f\u590f\u8f1d\u3001\u6e21\u9089 \u5b5d\u3001\u6a2a\u4e0a\u8056\u8cb4\u3001\u7af9\u5cf6\u79c0\u96c4\u3001\u5927\u6817\u4f38\u884c\u3001\u5c71\u4e0b \u7be4\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u4e2d\u99ac\u79c0\u6a39\u3001\u6c60\u7530\u5eb7\u535a\uff0e\u5916\u8ee2\u795e\u7d4c\u5358\u72ec\u9ebb\u75fa\u3067\u767a\u75c7\u3057\u305f\u6d77\u7dbf\u9759\u8108\u6d1e\u90e8\u306e\u8edf\u9aa8\u8089\u816b\u306e1\u4f8b\uff0e\u773c\u79d1\u81e8\u5e8a\u7d00\u8981 2022; 15: 379-383<\/span><\/li>\n
    9. \u6771 \u771f\u7406\u6075\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u6cb3\u91ce\u731b\u55e3\u3001\u5713\u5d0e\u590f\u7f8e\u3001\u690d\u91ce\u5178\u5b50\u3001\u85e4\u5d0e \u78a7\u3001\u5927\u6817\u4f38\u884c\u3001\u4f50\u85e4 \u52c7\u4e00\u90ce\u3001\u5927\u897f\u6df3\u4ec1\u3001\u6842\u6728\u771f\u53f8\uff0e\u5375\u7ba1\u598a\u5a20\u6d41\u7523\u5f8c\u306b\u767a\u751f\u3057\u305f\u7d9a\u767a\u6027\u8179\u819c\u598a\u5a20\u306e\u4e00\u4f8b\uff0e\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c 2022; 46: 189-193<\/span><\/li>\n<\/ol>\n

      \u7dcf\u8aac<\/strong><\/span><\/p>\n

        \n
      1. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306e\u75c5\u7406\u3068\u767a\u75c7\u6a5f\u5e8f. \u751f\u4f53\u306e\u79d1\u5b66. 2022;73: 553-558.<\/span><\/li>\n
      2. \u76db\u53e3\u6df8\u9999\u3001\u9b4f\u3000\u5cfb\u6d38\uff1a\u5fb9\u5e95\u30ac\u30a4\u30c9DIC\u306e\u3059\u3079\u30662022-’23\uff0e19 \u75c5\u7406\u7d44\u7e54\uff0e\u6551\u6025\u30fb\u96c6\u4e2d\u6cbb\u7642 2022; 34: 584-587.\u00a0\u00a0<\/span><\/li>\n<\/ol>\n

        \u66f8\u7c4d<\/strong><\/span><\/p>\n

        \u00a0<\/p>\n

        \u5b66\u4f1a\u767a\u8868<\/strong><\/span><\/p>\n

          \n
        1. \u524d\u5ddd\u548c\u4e5f\u3001\u8fbb\u3000\u539a\u81f3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9808\u582f\u3000\u7dbe\u3001\u897f\u5e73\u8ce2\u4f5c\u3001\u67f4\u7530\u525b\u5fb3\u3001\u5f35\u3000\u660e\u6804\u3001\u897f\u4e95\u9f8d\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u30cf\u30a4\u30ea\u30b9\u30af\u51a0\u52d5\u8108\u306eTranslocator protein\u767a\u73fe\u306818<\/sup>F-FEDAC-PET\u306b\u3088\u308b\u691c\u51fa. \u7b2c111\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u795e\u6238\u5e02\u30014\/14-16, 2022\uff09<\/span><\/li>\n
        2. \u9b4f\u3000\u5cfb\u6d38\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u68ee\u3000\u6643\u4f51\u3001\u53e4\u5ddd\u3000\u8ca2\u4e4b\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u6025\u6027\u89e3\u96e2\u3092\u5408\u4f75\u3057\u305f\u5927\u52d5\u8108\u7dda\u7dad\u7b4b\u7570\u5f62\u6210. \u7b2c111\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u795e\u6238\u5e02\u30014\/14-16, 2022\uff09<\/span><\/li>\n
        3. \u524d\u5ddd\u548c\u4e5f\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u897f\u5e73\u8ce2\u4f5c\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u7560\u5c71\u91d1\u592a\u3001\u6d77\u5317\u5e78\u4e00\u3001\u67f4\u7530\u525b\u5fb3\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u708e\u75c7\u3068\u4f4e\u9178\u7d20\u74b0\u5883\u306f\u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u8840\u6813\u5f62\u6210\u80fd\u3092\u76f8\u52a0\u7684\u306b\u4ea2\u9032\u3055\u305b\u308b\uff0e\u7b2c44\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u4ed9\u53f0\u5e02\u30016\/23-25, 2022\uff09<\/span><\/li>\n
        4. \u6749\u7530\u5343\u6cf0\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u8840\u6db2\u51dd\u56faVIII\u56e0\u5b50\u306f\u52d5\u8108\u786c\u5316\u6027\u8840\u6813\u306e\u5f62\u6210\u3092\u4fc3\u9032\u3059\u308b\uff1a\u5bb6\u514e\u5185\u819c\u80a5\u539a\u8840\u6813\u30e2\u30c7\u30eb\u3067\u306e\u691c\u8a0e. \u7b2c44\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u4ed9\u53f0\u5e02\u30016\/23-25, 2022\uff09<\/span><\/li>\n
        5. \u5c0f\u5c71\u5f70\u5e73\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u658e\u85e4\u7950\u4ecb\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u5317\u6751\u548c\u96c4\u3001\u6d77\u5317\u5e78\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30b0\u30eb\u30bf\u30df\u30f3\u306f\u8840\u7ba1\u5e73\u6ed1\u7b4b\u7d30\u80de\u306e\u51dd\u56fa\u6d3b\u6027\u3092\u6291\u5236\u3059\u308b. \u7b2c54\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u4e45\u7559\u7c73\u5e02\u30017\/23, 24, 2022\uff09<\/span><\/li>\n
        6. \u524d\u5ddd\u548c\u4e5f\u3001\u8fbb\u3000\u539a\u81f3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9808\u582f\u3000\u7dbe\u3001\u897f\u5e73\u8ce2\u4f5c\u3001\u67f4\u7530\u525b\u5fb3\u3001\u5f35\u3000\u660e\u6804\u3001\u897f\u4e95\u9f8d\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30cf\u30a4\u30ea\u30b9\u30af\u51a0\u52d5\u8108\u306eTranslocator protein\u767a\u73fe\u306818<\/sup>F-FEDAC-PET\u306b\u3088\u308b\u691c\u51fa. Translocator protein\u306f\u51a0\u52d5\u8108\u4e0d\u5b89\u5b9a\u30d7\u30e9\u30fc\u30af\u5185\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306b\u5c40\u5728\u3057\u300118<\/sup>F-FEDAC-PET\u306f\u5bb6\u514e\u52d5\u8108\u786c\u5316\u75c5\u5909\u3092\u63cf\u51fa\u3059\u308b. \u7b2c54\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u4e45\u7559\u7c73\u5e02\u30017\/23, 24, 2022\uff09<\/span><\/li>\n
        7. \u524d\u5ddd\u548c\u4e5f\u3001\u79e6\u3000\u6d0b\u4e00\u3001\u9577\u5b89\u82f1\u6cbb\u3001\u4e38\u5c71\u6cbb\u5f66\u3001\u82b1\u725f\u79ae\u5bcc\u7f8e\u96c4\u3001\u5c71\u4e0b\u3000\u7be4\uff0e\u30b1\u30c1\u30b8\u30e3\u30f3\uff08\u30b1\u30b8\u30e3\u30f3\uff09\u304c\u539f\u56e0\u3068\u8003\u3048\u3089\u308c\u305fWesterman \u80ba\u5438\u866b\u75c7\u306e\u4e00\u4f8b\uff0e\u7b2c68\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u5b63\u7279\u5225\u7dcf\u4f1a\uff08\u76db\u5ca1\u5e02\u300111\/17, 2022\uff09<\/span><\/li>\n
        8. \u5927\u6817\u4f38\u884c\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u795e\u5c71\u3000\u7965\uff0c\u5927\u5ddd\u661f\u7f8e\uff0c\u6d45\u7530\u7950\u58eb\u90ce, \u5c71\u4e0b\u3000\u7be4. \u9759\u8108\u8840\u6813\u306b\u304a\u3051\u308b\u8840\u6db2\u51dd\u56faXI\u56e0\u5b50\u306e\u5c40\u5728\u3068\u8840\u6813\u5f62\u6210\u3084\u6b62\u8840\u306b\u304a\u3051\u308b\u4f5c\u7528. \u7b2c27\u56de\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a\uff08\u5c90\u961c\u5e02\u300111\/26, 27, 2022\uff09<\/span><\/li>\n
        9. \u6e05\u6c34\u4e00\u6643\u3001\u5c71\u7530\u9686\u76db\u3001\u5e02\u6765\u4f38\u5f66\u3001\u6ff5\u7530\u8056\u6681\u3001\u5e02\u539f\u660e\u5b50\u3001\u4e03\u5cf6\u7be4\u5fd7\u3001\u90fd\u7bc9\u3000\u8ad2\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u76db\u53e3\u6e05\u9999. \u8853\u524d\u306b\u75c5\u7406\u8a3a\u65ad\u3057\u5f97\u305f\u5c0f\u8178\u539f\u767a\u60aa\u6027\u9ed2\u8272\u816b\u306e1\u4f8b. \u7b2c84\u56de\u65e5\u672c\u81e8\u5e8a\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a(\u798f\u5ca1\u5e02\u300111\/24-26,2022)<\/span><\/li>\n<\/ol>\n

          \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u306a\u3069<\/strong><\/span><\/p>\n

            \n
          1. \u6d45\u7530\u7950\u58eb\u90ce. \u5ca1\u672cShousuke Award\u53d7\u8cde\u8b1b\u6f14. \u7b2c44\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4ed9\u53f0\uff082022\uff09<\/span><\/li>\n
          2. \u9b4f\u3000\u5cfb\u6d38\u3001\u5c71\u4e0b\u3000\u7be4. \u764c\u95a2\u9023\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u75c5\u7406\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c54\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a. \u4e45\u7559\u7c73\uff082022\uff09<\/span><\/li>\n
          3. \u5c71\u4e0b\u3000\u7be4. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u75c5\u7406\u3068\u52d5\u8108\u786c\u5316\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c54\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a. \u4e45\u7559\u7c73\uff082022\uff09<\/span><\/li>\n
          4. \u6d45\u7530\u7950\u58eb\u90ce. \u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u8840\u6813\u5f62\u6210\u6a5f\u5e8f\uff08\u4f1a\u9577\u8b1b\u6f14\uff09. \u7b2c54\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a. \u4e45\u7559\u7c73\uff082022\uff09<\/span><\/li>\n
          5. \u9b4f\u3000\u5cfb\u6d38. \u764c\u95a2\u9023\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\uff1a\u6df1\u90e8\u9759\u8108\u8840\u6813\u3068\u80ba\u8840\u6813\u585e\u6813\u306e\u75c5\u7406\uff08\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c5\u56de\u65e5\u672c\u816b\u760d\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u6771\u4eac\uff082022\uff09<\/span><\/li>\n<\/ol>\n

            \u4e5d\u5dde\u6c96\u7e04\u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9<\/strong><\/span><\/p>\n

              \n
            1. \u5927\u6817\u4f38\u884c\uff1a\u5de6\u4e0b\u817f\u76ae\u819a\u75c5\u5909\uff08Lobular panniculitis with fat necrosis, pancreatic panniculitis\uff09<\/span>
              \u7b2c386\u56de\uff08\u7523\u696d\u533b\u79d1\u5927\u5b66\u3001\u5317\u4e5d\u5dde\u5e02\uff09<\/span><\/li>\n
            2. \u524d\u5ddd\u548c\u4e5f\uff1a\u5341\u4e8c\u6307\u8178\u816b\u760d\uff08Gastric-type adenocarcinoma in gastric-type adenoma\uff09<\/span>
              \u7b2c387\u56de\uff08\u4e5d\u5dde\u5927\u5b66\u3001\u798f\u5ca1\u5e02\uff09<\/span><\/li>\n
            3. \u5927\u6817\u4f38\u884c\uff1a\u5f8c\u8179\u819c\u816b\u760d\uff08Mucinous carcinoma\uff09<\/span>
              \u7b2c388\u56de\uff08\u718a\u672c\u8d64\u5341\u5b57\u75c5\u9662\u3001\u718a\u672c\u5e02\uff09<\/span><\/li>\n
            4. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u80ba\u816b\u760d\uff08Solitary fibrous tumor with intercalated duct hyperplasia\uff09<\/span>
              \u7b2c389\u56de\uff08\u9e7f\u5150\u5cf6\u5927\u5b66\u3001\u9e7f\u5150\u5cf6\u5e02\uff09<\/span><\/li>\n
            5. \u5927\u6817\u4f38\u884c\uff1a\u820c\u816b\u760d\uff08Sialadenoma papilliferum\uff09<\/span>
              \u7b2c390\u56de\uff08\u4f50\u8cc0\u4e2d\u90e8\u75c5\u9662\u30fb\u4f50\u8cc0\u75c5\u9662\u3001\u4f50\u8cc0\u5e02\uff09<\/span><\/li>\n<\/ol>\n

              \u53d7\u8cde<\/strong><\/span><\/p>\n

                \n
              1. \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a \u5ca1\u672cShosuke Award\u3000\u3000\u6d45\u7530\u7950\u58eb\u90ce<\/span><\/span><\/li>\n
              2. \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a \u512a\u79c0\u30dd\u30b9\u30bf\u30fc\u8cde\u3000\u3000\u524d\u5ddd\u548c\u4e5f<\/span><\/span><\/li>\n<\/ol>\n

                \u00a0<\/p>\n

                \u00a0<\/p>\n

                \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"

                \u539f\u8457\u8ad6\u6587 Sasaki S, Nishihira K, Yamashita A, Fujii T, Onoue K, Saito Y, Hatakeyama K, Shibata Y, Asada Y, Ohbayash … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":96,"featured_media":0,"parent":17,"menu_order":-17,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/666"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/comments?post=666"}],"version-history":[{"count":4,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/666\/revisions"}],"predecessor-version":[{"id":671,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/666\/revisions\/671"}],"up":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/17"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/media?parent=666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}